Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TRDA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
TRDA
Entrada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TRDA
Entrada Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
TRDA
with
LLY
Uncorrelated: r 0.23 · 499D.
Shared co-movers
1
with TRDA
with LLY
VRTX
Vertex Pharmaceuticals Inc
r 0.25
r 0.35
TRDA, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
TRDA
Entrada Therapeutics, Inc.
Change
4.69
▲
+3.37%
Mkt cap
$176.6M
Revenue
$898,000
Q2 FY26
Revenue
$25M
FY25
LLY
ELI Lilly & Co
Change
1,411.93
▼
−0.40%
Regular session
Nov 2 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 2 '26
TRDA
Entrada Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
4.69
▲
+3.37%
Price
1,411.93
▼
−0.40%
$176.6M
Mkt cap
$1.3T
Q2 FY26
$898,000
Revenue
$24.4B
Q3 FY26
FY25
$25M
Revenue
$65.2B
FY25
Change
Change
TRDA
4.69
▲
+3.37%
vs
LLY
1,411.93
▼
−0.40%
Regular session
Nov 2 '26